Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



A Trial to Evaluate Safety and Tolerability of TST001 in Advanced or Metastatic Solid Tumors

Multiple Cancer Types

This is an open label Phase 1, First in Human trial of TST001, a recombinant humanized anti-Claudin 18.2 (CLDN18.2) IgG1 monoclonal antibody. It is being tested against advanced and / or metastatic solid tumors including gastric, gastroesophageal junction, pancreatic, colon and lung cancers.
Miscellaneous, Phase I
I
Berlin, Jordan
NCT04396821
VICCPHI2047

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: